top of page

Screening of inFlammation to enable personalized Medicine

Together we reach the next level of diagnostics

Home: Welcome

Millions of people in the European Union suffer from diseases associated with dysregulation of the complement system, which is a major component of

the immune system.


  • approximately 3,300 new cases of bacterial infections such as invasive meningococcal disease are diagnosed per year in infants and young children in the EU

  • about 200,000 young adults in Europe suffer from chronic inflammation of the kidney

  • 15 million elderly European residents are affected by limited vision due to age-related macular degeneration.

Scientist in the Lab
Learn more

SciFiMed will

  •  investigate the pathophysiology of the FH-protein family,

to enable

  • the development of personalized, radically new on-time diagnostics,

which allow

  • improved patient stratification for prospective cohort studies

  • understand complement-associated diseases.

SciFiMed is a multi-disciplinary project and will combine fundamental immunological research with novel nanomaterial-based biosensor development translated into proof-of-principle diagnostics.

SciFiMed will revolutionize doctors’ ability to diagnose and treat severe inflammatory diseases plaguing millions of Europeans.


Thanks for submitting!

bottom of page